Literature DB >> 34921672

Autophagy and Hepatic Tumor Microenvironment Associated Dormancy.

Yunus Akkoc1, Devrim Gozuacik2,3.   

Abstract

The goal of successful cancer treatment is targeting the eradication of cancer cells. Although surgical removal of the primary tumors and several rounds of chemo- and radiotherapy reduce the disease burden, in some cases, asymptomatic dormant cancer cells may still exist in the body. Dormant cells arise from the disseminated tumor cells (DTCs) from the primary lesion. DTCs escape from immune system and cancer therapy and reside at the secondary organ without showing no sign of proliferation. However, under some conditions. dormant cells can be re-activated and enter a proliferative state even after decades. As a stress response mechanism, autophagy may help the adaptation of DTCs at this futile foreign microenvironment and may control the survival and re-activation of dormant cells. Studies indicate that hepatic microenvironment serves a favorable condition for cancer cell dormancy. Although, no direct study was pointing out the role of autophagy in liver-assisted dormancy, involvement of autophagy in both liver microenvironment, health, and disease conditions has been indicated. Therefore, in this review article, we will summarize cancer dormancy and discuss the role and importance of autophagy and hepatic microenvironment in this context.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Autophagy; Dormancy; Liver; Tumor microenvironment

Mesh:

Year:  2021        PMID: 34921672     DOI: 10.1007/s12029-021-00774-z

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  124 in total

Review 1.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

2.  The distribution of secondary growths in cancer of the breast. 1889.

Authors:  S Paget
Journal:  Cancer Metastasis Rev       Date:  1989-08       Impact factor: 9.264

Review 3.  EMT, cell plasticity and metastasis.

Authors:  Christine L Chaffer; Beatriz P San Juan; Elgene Lim; Robert A Weinberg
Journal:  Cancer Metastasis Rev       Date:  2016-12       Impact factor: 9.264

Review 4.  Anoikis molecular pathways and its role in cancer progression.

Authors:  Paolo Paoli; Elisa Giannoni; Paola Chiarugi
Journal:  Biochim Biophys Acta       Date:  2013-07-02

5.  Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice.

Authors:  M Brown; F P Assen; A Leithner; J Abe; H Schachner; G Asfour; Z Bago-Horvath; J V Stein; P Uhrin; M Sixt; D Kerjaschki
Journal:  Science       Date:  2018-03-23       Impact factor: 47.728

6.  A critical step in metastasis: in vivo analysis of intravasation at the primary tumor.

Authors:  J B Wyckoff; J G Jones; J S Condeelis; J E Segall
Journal:  Cancer Res       Date:  2000-05-01       Impact factor: 12.701

Review 7.  Framework models of tumor dormancy from patient-derived observations.

Authors:  Christoph A Klein
Journal:  Curr Opin Genet Dev       Date:  2010-12-08       Impact factor: 5.578

8.  Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression.

Authors:  L Holmgren; M S O'Reilly; J Folkman
Journal:  Nat Med       Date:  1995-02       Impact factor: 53.440

9.  Anoikis resistance: an essential prerequisite for tumor metastasis.

Authors:  Yong-Nyun Kim; Kyung Hee Koo; Jee Young Sung; Un-Jung Yun; Hyeryeong Kim
Journal:  Int J Cell Biol       Date:  2012-02-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.